lated Disorders”); sedative-, hypnotic-, or anxiolytic-induced depressive disorder (“De-
pressive Disorders”); sedative-, hypnotic-,  or anxiolytic-induced anxiety disorder
(“Anxiety Disorders”); sedative-, hypnotic-, or  anxiolytic-induced sleep disorder (“Sleep-
Wake Disorders”); sedative-, hypnotic-, or anxiolytic-induc ed sexual dysfunction (“Sex-
ual Dysfunctions”); and sedative-, hypnotic-, or anxiolytic-induced major or mild neuro-
cognitive disorder (“Neurocog nitive Disorders”). For seda tive, hypnotic, or anxiolytic
intoxication delirium and sedative, hypnotic, or anxiolytic withdrawal delirium, see the
criteria and discussion of delirium in the chapter “Neurocognitive Disorders.” These sed-
ative-, hypnotic-, or anxiolytic-induced disorders are diagnosed inst ead of sedative, hyp-
notic, or anxiolytic intoxication or sedative, hypnotic, or anxiolytic withdrawal only when
the symptoms are sufficiently severe to  warrant independent clinical attention.
Unspecified Sedative-, Hypnotic-,
or Anxiolytic-Related Disorder
292.9 (F13.99)
This category applies to presentations in which symptoms characteristic of a sedative-,
hypnotic-, or anxiolytic-related disorder that cause clinically significant distress or impair-
ment in social, occupational, or other impor tant areas of functioning predominate but do
not meet the full criteria for any specific s edative-, hypnotic-, or anxiolytic-related disorder
or any of the disorders in the substance-related and addictive disorders diagnostic class.